On 10 February 1997 France requested that the CPMP, under Article 12 of Council Directive 75/ 319/ EEC as amended, give an opinion on whether there is an unfavourable benefit/ risk ratio for terfenadine in relation to its arrhythmogenic potential and to its serious cardiac adverse effects.